Drug Trial Radar · NCT06154304
BE Study of Albuterol Sulfate Inhalation Aerosol 90 mcg Per Actuation in Patients With Stable Mild Asthma
Last checked: Nov 20, 2026Latest source record: Jul 16, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
120
Actual
Start
Dec 6, 2023
Primary completion
Sep 16, 2024
Study completion Nov 29, 2024
Sponsor
- Lead sponsor
- Cipla Ltd.Industry
- Sponsor type
- Industry
- First posted
- Dec 4, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to demonstrate the pharmacodynamic bioequivalence of the test product to the reference product, using bronchoprovocation (methacholine challenge testing) in adult patients with stable mild asthma.
Conditions
- Bronchial Asthma
Interventions
Albuterol Sulfate Inhalation Aerosol (90 mcg per actuation)Drug
90 mcg
Ventolin HFA 90Mcg/Actuation Inhalation Aerosol_#1Drug
90 mcg
Ventolin HFA, 90 Mcg/Inh Inhalation Aerosol_#2Drug
180 mcg
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Provocative Dose of Methacholine Causing 20 % Fall (PD20) in FEV1(Forced Expiratory Volume in 1 second)Time frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Velocity CLinical Research
Medford, Oregon
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.